Medicare to Cover Breakthrough Gene Therapy for Some Cancers
August 9, 2019
(ABC News) – Expanding access to a promising but costly treatment, Medicare said Wednesday it will cover for some blood cancers a breakthrough gene therapy that revs up a patient’s own immune cells to destroy malignancies. Officials said Medicare will cover CAR-T cell therapies for certain types of lymphoma and leukemia , uses that are approved by the Food and Drug Administration. The cost can run to hundreds of thousands of dollars per patient, not counting hospitalization and other expenses.